Serum Urokinase Plasminogen Activator as a Novel Biological Marker for COPD- A Review

Journal Title: Journal of Clinical and Diagnostic Research - Year 2019, Vol 13, Issue 7

Abstract

ABSTRACT Chronic Obstructive Pulmonary Disease (COPD), a progressive disease of the airways is associated with chronic inflammation of respiratory passages that leads to irreversible lung dysfunction and distinct morphological changes. The progressive increase in airflow limitation that is seen in COPD is associated with systemic inflammation with the development of extra-pulmonary complications like muscle atrophy, cachexia and osteoporosis. Several biomarkers like C-Reactive Protein (CRP), fibrinogen and Interleukin have been used as an adjunct tool to diagnose COPD. Soluble Urokinase Plasminogen Activator Receptor (suPAR) has been used as a diagnostic marker for congestive heart failure, sepsis, adult respiratory distress syndrome and acute exacerbation COPD. The present narrative review gives a brief overview on clinical significance of suPAR in the diagnosis and prognosis of COPD. The articles quoted in this review were taken from search engines like PubMed Central, Crossref, Web of Science and Google Scholar for articles published from 1991 to 2016, by using domain words like “COPD”, “suPAR”, “inflammation” and “prognosis”. The relevant references cited in these articles were also reviewed.

Authors and Affiliations

D Rekha, Priscilla Johnson, Subhasis Das, B Rajagopalan, GR Sathya

Keywords

Related Articles

Neonatal Airway Compromise by a Giant Cervicothoracic Venous Haemangioma

Haemangiomas are most common non-malignant vascular tumours of infancy. Here, we describe an antenatally detected mass over the neck causing compressive respiratory compromise at birth requiring resuscitative measures at...

Index/Ring Finger Ratio, Hand and Foot Index: Gender Estimation Tools

Introduction: Gender estimation from dismembered human body parts and skeletal remains in cases of mass disasters, explosions, and assaults cases is an imperative element of any medico-legal investigations and has been a...

A Prospective Analysis of Drug Interactions in Patients of Intensive Cardiac Care Unit

Introduction: Drug-Drug Interaction (DDI) is a serious concern in cardiac patients due to polypharmacy. Aim: The present study was aimed to identify the potential DDI among hospitalized cardiac patients and evaluate the...

A Rare Presentation of an Incomplete Vertical Fracture in the Furcation Area of a Mandibular Molar and its Multidisciplinary Management

Specialists in the dental field often get habituated to having a partial or biased assessment of clinical findings or disorders by virtue of practicing a niche speciality over long periods of time. This can lead to a dis...

Treatment of Plaque Psoriasis by 308 nm Excimer Light in Egyptian Patients

ABSTRACT Introduction: Psoriasis is a chronic skin condition that demonstrates a high burden and an impaired quality of life. The role of excimer light therapy and its modes of action are not completely understood in the...

Download PDF file
  • EP ID EP606967
  • DOI 10.7860/JCDR/2019/41763.12979
  • Views 110
  • Downloads 0

How To Cite

D Rekha, Priscilla Johnson, Subhasis Das, B Rajagopalan, GR Sathya (2019). Serum Urokinase Plasminogen Activator as a Novel Biological Marker for COPD- A Review. Journal of Clinical and Diagnostic Research, 13(7), 1-4. https://europub.co.uk./articles/-A-606967